GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Iran Daru (XTEH:IRDR1) » Definitions » Change In Receivables

Iran Daru (XTEH:IRDR1) Change In Receivables : IRR0.00 Mil (TTM As of . 20)


View and export this data going back to 1990. Start your Free Trial

What is Iran Daru Change In Receivables?

Iran Daru's change in receivables for the quarter that ended in . 20 was IRR0.00 Mil. It means Iran Daru's Accounts Receivable stayed the same from . 20 to . 20 .

Iran Daru's change in receivables for the fiscal year that ended in . 20 was IRR0.00 Mil. It means Iran Daru's Accounts Receivable stayed the same from . 20 to . 20 .

Iran Daru's Accounts Receivable for the quarter that ended in . 20 was IRR0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Iran Daru's liquidation value for the six months ended in . 20 was IRR0.00 Mil.


Iran Daru Change In Receivables Historical Data

The historical data trend for Iran Daru's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Iran Daru Change In Receivables Chart

Iran Daru Annual Data
Trend
Change In Receivables

Iran Daru Semi-Annual Data
Change In Receivables

Iran Daru Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Change In Receivables for the trailing twelve months (TTM) ended in . 20 was IRR0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Iran Daru  (XTEH:IRDR1) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Iran Daru's Days Sales Outstanding for the quarter that ended in . 20 is calculated as:

2. In Ben Graham's calculation of liquidation value, Iran Daru's accounts receivable are only considered to be worth 75% of book value:

Iran Daru's liquidation value for the quarter that ended in . 20 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Iran Daru Change In Receivables Related Terms

Thank you for viewing the detailed overview of Iran Daru's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Iran Daru (XTEH:IRDR1) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Ayatollah Saeedi Highway, End Of Kermani Street, Moallem Boulevard, Tehran, IRN, 1371658111
Iran Daru is a pharmaceutical company based in Iran. It manufactures and sells pharmaceutical products for antibiotics, cardiovascular agents, and local anesthetic agents. The company manufactures products in three main dosage form categories namely solid, semi-solid, and liquid including tablets, capsules, pellets, sachets, gels, creams, ointments (sterile and non-sterile), spray solutions, and syrups. Products offered by Iran Daru include Diclofenac Potassium, Biotin 5 mg, Tetracycline, Folic acid, Meloxicam, Acetaminophen and Caffeine, and Levocetirizine dihydrochloride, among others. It also exports its products to other countries.

Iran Daru (XTEH:IRDR1) Headlines

No Headlines